Q: What is the purpose of this website?

A: This is an educational website about fibromyalgia (FM) and myofascial pain syndrome (MPS).  Although there are sections written primarily for patients and primarily for caregivers, there is full access to all materials and visitors are encouraged to explore all sections.  For example, there is a great deal of information in the handouts for care providers that may be of interest to patients.  Patients may want to provide specific references for people on their medical care teams.  The information on this website is not intended as a substitution for professional medical care.

Q. Where did this material originate?

A. Much of this material is from books or handouts written by Devin Starlanyl.  Some is adapted from the books Devin wrote.  Please be aware that we cannot supply all the information from our books on the website.  The website is maintained by EnigamI, Inc.

Q. Who is Devin Starlanyl?

A. Devin’s formal medical training was in emergency medicine. She also has experience in hospice work, 4 years in local public health, 8 years as technical director of Chemdex, Inc. parenteral pharmaceutical manufacturing including working with the FDA setting up bioavailability studies, Emergency Planner for Vermont Yankee Nuclear (ER and local emergency drills, special needs program, etc.).

What Devin learned about FM and MPS was acquired after formal schooling was over.  Devin has completed many hours of Continuing Medical Education credits in FM, MPS and related medical topics.  Through much of this, Devin has had the help of mentor David G. Simons, co-author of the definitive texts on myofascial medicine with Janet G. Travell (JFK’s White House physician).  Devin is also a Mensa member, and a t’ai chi player.  

Devin is primarily retired, but has been a consultant in the field of FM and MPS for decades. Besides numerous articles in newsletters, these are some of her relevant publications:

• Starlanyl DJ and Sharkey J. 2013. Healing through Trigger Point Therapy: A Guide to Fibromyalgia , Myofascial Pain and Dysfunction." Lotus, North Atlantic, Random /House.
• Starlanyl J. 2006.Comment on Canadian Consensus Document on Fibromyalgia Syndrome. J Musculoskel Pain 14(4):75-81.
• Starlanyl DJ, Jeffrey JL, Roentsch G, Taylor-Olson C. 2001-2. The effect of transdermal T3 (3,3',5-triiodothyronine) on geloid masses found in patients with both fibromyalgia and myofascial pain: double-blinded, N of 1 clinical study. Myalgies 2(2):8-18.
• Starlanyl, D. T'ai Chi Chuan and Musculoskeletal Pain. 2001. T'ai Chi Magazine 25(4)53-55.
• Starlanyl DJ and Jeffrey JL. 2001. The presence of geloid masses in a patient with both fibromyalgia and chronic myofascial pain. Phys Ther Case Rep 4(1):22-31.
• Starlanyl DJ. and ME. Copeland. 2001. Fibromyalgia and Chronic Myofascial Pain: A Survival Manual. Edition 2. Oakland: New Harbinger Publications.
• Eisinger J, Starlanyl D, Blotman F, Bueno L et al. 2000. [Protocole d'informations anonyme sure les fibromyalgiques.] Med du Sud-Est 1:9-13. [French].
• Eisinger J, Milliat M, Garnier R, Starlanyl D. 2000. [Commentaries sur un questionnaire "fibromyalgie" detaille.] Myalgies 1(3):1-3. [French].
• Shankland, Wesley E. 2000. The Challenge of Facial Pain Columbus: AOmega Publishing Co. Columbus. Chapter 10: Fibromyalgia, Myofascial Pain Syndrome and Orofacial Pain by Devin J. Starlanyl
• Starlanyl DJ. 1999. The Fibromyalgia Advocate. Oakland: New Harbinger Publications.
• Starlanyl, DJ 1999. Worlds of Power, Lines of Light. Devstar Publications.
• Starlanyl DJ 1997. Chronic Myofascial Pain Syndrome: A Guide to the Trigger Points. Oakland: New Harbinger. 2 hour video.
• Starlanyl DJ. 1997. Fibromyalgia and Myofascial Pain Syndrome: A Special Challenge. Clin Bull Myofas Ther 2 (2/3): 75-89.
• Starlanyl DJ. and ME. Copeland. 1996. Fibromyalgia and Chronic Myofascial Pain: A Survival Manual. Edition 2. Oakland: New Harbinger Publications.
• Starlanyl DJ.1995. "Comment on Granges and Littlejohn's. "Prevalence of myofascial pain syndrome in fibromyalgia and regional pain syndrome: A comparative study." J Musculoskel Pain 3 (1):129-132.
• Starlanyl DJ 1994. "Comment on article by Hong, Chen, Pon and Yu, "Intermediate effects of various physical medicine modalities on pain threshold of an active myofascial trigger point." J Musculoskel Pain 2 (2):141-142.
• Starlanyl, DJ Planetary Habitability : Adaptability in Tardigrada.

Q. How do I contact Devin Starlanyl?

A. Devin’s biggest challenge is to pace herself.  Devin is not available as an Expert Witness or to otherwise speak in court cases, nor can she review case histories.  Working on the computer is a major perpetuating factor for some myofascial trigger points. Many of your questions are answered in the books and on this website. PLEASE DO NOT ATTEMPT TO CONTACT DEVIN THROUGH OTHER PEOPLE OR THROUGH HER INTERNET CARRIER.